After the Bell
Before the Bell
Jim Cramer's Daily Booyah
Winners & Losers
SOURCE Rosetta Genomics Ltd.
Rosetta Genomics (ROSG) stock surged on Friday after Cantor Fitzgerald initiated coverage on the stock with a 'speculative buy' rating.
These biotech stocks are within range of triggering breakout trades. Here's how to trade them now.
Rosseta Genomics (ROSG) shares are climbing after analysts at Cantor upgraded the stock to 'buy' from 'hold' today.
Rosetta Genomics (ROSG) shares are up double digits after the company announced that it received a patent for its cancer diagnostic assay.
©1996-2016 TheStreet, Inc. All rights reserved.
Action Alerts PLUS is a registered trademark of TheStreet, Inc.